Open Access 24-11-2023 | Clostridioides Difficile | Correction
Correction to: RBX2660 (REBYOTA®) in preventing recurrence of Clostridioides difficile infection: a profile of its use in the USA
Published in: Drugs & Therapy Perspectives | Issue 12/2023
Login to get access